It is not uncommon for viruses to mutate and develop resistance to drugs and vaccines but research suggests that is not happening with the novel coronavirus. “The good news is that because it’s not changing appreciably, we could reasonably argue that vaccines would work against most of the strains out there,” said UTMB’s Vineet Menachery. Yahoo! News also distributed this story.

A local report on the pressure cuff emergency ventilator developed by UTMB’s Chris Zahner and Aisen Chacin.

Health care professionals fighting COVID-19 say there is a shortage nationally of ventilators. Now UTMB’s Chris Zahner and Aisen Chacin have developed a pressure cuff emergency ventilator using common hospital supplies.

Beaumont’s NBC affiliate interviewed UTMB’s Scott Weaver for an update on COVID-19 research and potential vaccine developments. “So we’ve been gearing up research very quickly and we have a wide range of different projects up and running here,” Weaver said.

Brazoria County coverage of Dr. Raimer’s press briefing with local reporters. “We did see this coming,” Raimer said. “We have gained a lot of knowledge about what is happening.”

Plans by UTMB to address a projected surge in hospitalizations because of COVID-19 were outlined yesterday on a conference call with local reporters hosted by ad interim president Dr. Ben Raimer. “Success in playing hockey is knowing where the puck is going to go in the next few seconds,” said Raimer. “We’re trying to look at where the disease is going to go in the next few weeks. We’ll be constantly updating and bringing new things online.”

Health care professionals fighting COVID-19 say there is a shortage nationally of ventilators. Now UTMB’s Chris Zahner and Aisen Chacin have developed a pressure cuff emergency ventilator using common hospital supplies.

An in-depth look at difficult measures needed to defend the nation again COVID-19. UTMB’s James Le Duc is one of the experts providing guidance in the story. DNyuz and The Minneapolis Star Tribune republished the story.

Around the world research teams are screening multiple drugs and compounds in a search to find one or more that would help treat patients with COVID-19. One drug in particular, hydroxychloroquine, has generated a lot of interest. According to UTMB’s Susan McLellan it is too early to know how well the drug might work.